Thus, altered Tfh/Tfr imbalance may be a potential therapeutic target for IBD, while Tnfaip6 might also be expected to become an alternative treatment option for MSC transplantation in IBD in the future. The gene discussed is TFRC; the disease is inflammatory bowel disease.